Skip to main content

    Maxim Group downgrades BioRestorative Therapies (BRTX) to Hold

    GNG Research Market News

    By GNG Research

    Maxim Group downgraded BioRestorative Therapies Inc (BRTX) to Hold from Buy on October 6, 2026.

    Among one firm active over the past 90 days, zero hold a bullish rating. The consensus price targets from three analysts as of October 30, 2026, have a mean of $306.00, a median of $306.00 and a range of $303.00 to $315.00.

    Consensus Q4 FY2026 EPS is -$2.04, with revenue at $395,250. The next earnings report is on November 10, 2026.